Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Vitamin D3 × Cholecalciferol × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Osteoporosis 4 Prostatic Neoplasms 3 Breast Neoplasms 3 Vitamin D Deficiency 2 Polycystic Ovary Syndrome 2 Neoplasms 2 Cardiovascular Diseases 2 Vitamin D3 1 Neuroma 1 Melanoma, Cutaneous Malignant 1 Melanoma 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Lymphoma, B-Cell, Marginal Zone 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Leukemia, B-Cell 1 Insulin Resistance 1 Fractures, Bone 1 Colorectal Adenocarcinoma 1

Interventions

Cholecalciferol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03389659 2018-01-03

XELOX/mFOLFOX Plus Vitamin D3 vs. XELOX/mFOLFOX as Firstline Chemotherapy in mCRC

Tianjin Medical University Cancer Institute and Hospital

Phase 3 Unknown

Vitamin D3

Data powered by HemOnc (CC BY 4.0) Colophon ⚡